
|Articles|July 8, 2008
Etanercept demonstrates therapeutic effect on keloids
National report - A study shows that intralesional etanercept may provide an effective treatment for keloids, according to TherapeuticsDaily.
Advertisement
National report
- A study shows that intralesional etanercept may provide an effective treatment for keloids, according to TherapeuticsDaily.
Investigators tested an intralesional corticosteroid (triamcinolone acetonide/TAC) against intralesional etanercept (Enbrel, Amgen/Wyeth). Researchers found the intralesional corticosteroids down-regulate collagen gene expression, alter glycosaminoglycans and decrease fibroblast proliferation.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Phase 3 Data Position Zasocitinib as a Potential New Oral Option for Psoriasis
2
FDA Clears IND Application of Recludix’s Oral STAT6, REX-8756
3
Practical Approaches to Managing Atopic Dermatitis With Topical Therapies
4
Highlighting Major Breakthroughs for Atopic Dermatitis and Psoriasis in 2025
5

















